Media Newsroom of

TRICCAR Holdings, Inc.

Follow on Social Network
848 N. Rainbow Blvd., Suite 1888
Las Vegas, Nevada - 89107 United States
Phone: 702-330-2430
TRICCAR Holdings, Inc.

TRICCAR is a pharmaceutical research and development company targeting the world’s most devastating diseases: cancer, obesity, ALS, trigeminal neuralgia, fibromyalgia, diabetic and other nerve diseases, hypothyroidism, and pain through prescription and dietary supplements.

We are a cultivation, research and development pharmaceutical company based in Las Vegas, Nevada, USA that is focused on investigational research of naturally-derived formulas and their applications to the treatment of common health issues.

Our investigational approach to disease abatement includes natural alternatives to toxic procedures and drugs that have been shown to kill tissue, cause organ damage, weaken immunity, or otherwise produce side effects that are sometimes worse than the diseases they treat.

Through joint venture partners and our own efforts we are advancing iPS stem cell research through gene delivery and recoding of adult stem cells to embryonic stem cells and developing state-of-the-art growing protocols and technologies with the goal of finding cures for common diseases, thus giving millions of afflicted people hope for a better tomorrow.

TRICCAR announces results of first patient study of its Organ Fat Formula (OFF©)

TRICCAR announces results of first patient study of its Organ Fat Formula (OFF©)

TRICCAR Holdings, Inc., aka, TRICCAR, today announced initial test results of its first nutraceutical dietary supplement to combat obesity. A 60-day double blind study of the Company's Organ Fat Formula resulted in an average weight loss of 21 pounds.Bill Townsend,…


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login